Congress expands quantum research to include molecular simulation

What it does

This bill amends the National Quantum Initiative Act to formally include quantum modeling and simulation as part of the federal quantum information science research program. It adds 'modeling, simulation' to the statutory definition of quantum information science and directs the research program to fund quantum molecular modeling and simulation projects alongside existing quantum computing work. The bill does not create new agencies or spending; it expands the scope of an existing research initiative to cover molecular simulation applications in drug development, materials science, battery technology, and fertilizer production.

Why we flagged it

The bill is a straightforward amendment to an existing federal research initiative, broadening its scope to include quantum molecular modeling and simulation alongside quantum computing. It is not a tax measure, appropriation, or regulatory change—purely a definitional and programmatic expansion.

What the text implies

• Expansion of quantum research scope may accelerate private-sector adoption of quantum simulation tools if federal research produces open-source or licensed intellectual property, creating downstream commercial opportunities in pharmaceuticals, materials, and energy sectors.
• The bill does not specify funding levels or appropriations; actual expansion of research depends on future budget allocations to the National Quantum Initiative, which may or may not materialize.
• Inclusion of quantum molecular modeling in the federal research mandate may shift competitive advantage toward institutions and companies with existing quantum computing infrastructure, potentially concentrating benefits among well-funded research universities and tech firms.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill expands federal research funding eligibility to include quantum molecular simulation, a field with stated applications in drug development, battery technology, materials science, and sustainable agriculture. Broader research funding typically accelerates innovation and reduces barriers to entry for researchers, which can yield public benefits in healthcare, energy, and environmental sustainability. No restrictions on citizen rights, protections, or remedies are imposed.

Who stands to gain

• research universities and national laboratories (expanded funding eligibility)
• quantum computing hardware vendors (increased demand for simulation-capable systems)
• pharmaceutical companies (potential downstream applications in drug discovery)
• materials science and battery technology firms (potential downstream applications)

Named in the bill

National Quantum Initiative Act, House Committee on Science, Space, and Technology, federal research institutions, quantum computing industry

Where it stands

12 cosponsors: 8 Republicans, 4 Democrats.

• Mar 2, 2026 — Introduced · Congress.gov: “Introduced in House”
• Mar 2, 2026 — Referred to House Committee on Science, Space, and Technology · Congress.gov: “Referred to the House Committee on Science, Space, and Technology”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

3 lobbying clients named this bill on 3 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $220,000 in lobbying spend. A filing names 1 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 61% of bills with at least one filing.

Randy Feenstra, the sponsor, reported $570,750 in PAC receipts in the 2026 cycle.

• D-wave Government Inc. — $150,000 on 1 filing
• Quantum Industry Coalition — $50,000 on 1 filing
• D-wave Government Inc. — $20,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.